SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kraig Biocraft Laboratories, Inc. – ‘S-1/A’ on 4/14/21 – ‘EX-5.2’

On:  Wednesday, 4/14/21, at 4:30pm ET   ·   Accession #:  1493152-21-8737   ·   File #:  333-255041

Previous ‘S-1’:  ‘S-1’ on 4/5/21   ·   Next:  ‘S-1/A’ on 4/15/21   ·   Latest:  ‘S-1/A’ on 11/22/23   ·   16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/14/21  Kraig Biocraft Laboratories, Inc. S-1/A                  2:161K                                   M2 Compliance LLC/FA

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML     43K 
                (General Form)                                                   
 2: EX-5.2      Opinion of Counsel re: Legality                     HTML     14K 


‘EX-5.2’   —   Opinion of Counsel re: Legality


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 5.2

 

 

     

 

Owner:

 

R. Justin Tynsky

95 East Flaming Gorge Way

Green River, WY 82935

(307) 875-3909

Fax: 307-939-2029

rjtynsky@tynskylawoffice.com

 

Associates:

 

Nicholas Vanatta

95 East Flaming Gorge Way

Green River, WY 82935

(307) 875-3909

Fax: 307-939-2029

nvanatta@tynskylawoffice.com

 

David Harmon

95 East Flaming Gorge Way

Green River, WY 82935

(307) 875-3909

Fax: 307-939-2029

dharmon@tynskylawoffice.com

 

April 5, 2021

 

Kraig Biocraft Laboratories, Inc.

2723 South State St. Suite 150

Ann Arbor, Michigan 48104

 

Ladies and Gentlemen:

 

We have acted as Wyoming counsel to Kraig Biocraft Laboratories, Inc., a Wyoming corporation in connection with Form S-1, including all amendments or supplements thereto (File No. 333-255041, the “Registration Statement”) for the registration of 207,750,197 shares of the Company’s common stock, which includes: (i) 160,875,161 shares of common stock underlying secured convertible notes pursuant to that certain securities purchase agreement dated as of March 26, 2021 between the Company and Yorkville (the “March Debenture”), (ii) 8,000,000 shares of common stock underlying a warrant dated March 26, 2021 (the “Yorkville Warrant”), (iii) 35,750,036 shares underlying an amended and restated convertible note that was originally issued in December 2020 (the “December Debenture,” together with the March Debenture, the “Debentures”), and (iv) 3,125,000 shares of common stock underlying a warrant issued in December 2020 (the “December Warrant,” together with the Yorkville Warrant, the “S1 Warrants”).

 

 

As such counsel and for purposes of our opinions set forth below, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials, and other instruments as we have deemed necessary or appropriate as a basis for the opinions set forth herein, including, without limitation:

 

1. a copy of the Articles of Incorporation of the Company certified by the Secretary of State of the State of Wyoming;

 

2. a copy of the Bylaws of the Company;

 

3. a copy of the Registration Statement; and

 

4. a copy of certificate issued by the Secretary of State of the State of Wyoming on March 25, 2021, as to the good standing of the Company in the State of Wyoming ;

 

 C: 
 C: 1Tynsky Law Office, P.C. 
 

 

Based upon the foregoing, and in reliance thereon we are of the following opinions:

 

1. The Company has been duly incorporated as a corporation in the state of Wyoming and is validly existing and in good standing with the state of Wyoming.

 

2. The authorized stock capital of the Company is of unlimited authorized shares, no par value, of Class A common stock and Class B common stock, and Series A preferred stock.

 

3. The issuance and allotment of the shares underlying the S1 Warrants and Debentures have been duly authorized and when allotted, issued and paid for as contemplated in the Registration Statement and the Prospectus, the Shares will be legally issued and allotted, fully paid and non-assessable.

 

This opinion letter deals only with the specified legal issues expressly addressed herein, and you should not infer any opinion that is not explicitly addressed herein from any matter stated in this opinion letter. The opinions expressed herein are to be governed by the laws of the State of Wyoming and shall be construed in accordance with the customary practice in Wyoming of lawyers who regularly give, and lawyers who regularly advise opinion recipients regarding, opinions of the kinds contained herein.

 

We consent to the filing of this opinion letter as an exhibit to the Registration Statement, the discussion of this opinion letter in the Registration Statement and to the references to our firm in the Registration Statement and the Prospectus. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act, or the rules and regulations promulgated thereunder, nor do we admit that we are experts with respect to any part of the Registration Statement within the meaning of the term “expert” as used in the Securities Act.

 

  Very truly yours,
     
  By:  /s/ Nicholas Vanatta
    Nicholas Vanatta (#7-5900)
    Tynsky Law Office
    P.O. Box 237
    Green River, WY 82935
    (307) 875-3909

 

 C: 
2Tynsky Law Office, P.C. 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:4/14/214
4/5/214,  S-1
3/26/218-K,  8-K/A
3/25/21
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/21  Kraig Biocraft Laboratories, Inc. S-1/A                  1:74K                                    M2 Compliance LLC/FA


15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/05/21  Kraig Biocraft Laboratories, Inc. S-1                   63:6M                                     M2 Compliance LLC/FA
 3/26/21  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,9 3/26/21   10:1.2M                                   M2 Compliance LLC/FA
 1/26/21  Kraig Biocraft Laboratories, Inc. 8-K:1,3,8,9 1/26/21    4:217K                                   M2 Compliance LLC/FA
12/11/20  Kraig Biocraft Laboratories, Inc. 8-K:1,2,8,912/11/20    5:541K                                   M2 Compliance LLC/FA
 6/02/20  Kraig Biocraft Laboratories, Inc. S-1                   71:7.9M                                   M2 Compliance LLC/FA
 3/27/20  Kraig Biocraft Laboratories, Inc. 10-K       12/31/19   62:4.6M                                   M2 Compliance LLC/FA
 3/31/15  Kraig Biocraft Laboratories, Inc. 10-K       12/31/14   50:4.1M                                   Issuer Direct/FA
 1/30/15  Kraig Biocraft Laboratories, Inc. S-1/A                  6:5.4M                                   Issuer Direct/FA
 1/21/15  Kraig Biocraft Laboratories, Inc. 8-K:5,7,9   1/20/15    3:98K                                    Issuer Direct/FA
12/19/13  Kraig Biocraft Laboratories, Inc. 8-K:3,5,9  12/17/13    2:901K                                   Issuer Direct/FA
 8/01/11  Kraig Biocraft Laboratories, Inc. S-1                    4:3.4M                                   EdgarAgents LLC/FA
 4/15/10  Kraig Biocraft Laboratories, Inc. 10-K       12/31/09    5:1.5M                                   EdgarAgents LLC/FA
 1/25/10  Kraig Biocraft Laboratories, Inc. S-1/A                  3:2.5M                                   EdgarAgents LLC/FA
 3/26/08  Kraig Biocraft Laboratories, Inc. 10KSB      12/31/07    4:881K                                   EdgarAgents LLC/FA
 9/26/07  Kraig Biocraft Laboratories, Inc. SB-2                   9:1.7M                                   EdgarAgents LLC/FA
Top
Filing Submission 0001493152-21-008737   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 10:46:15.2am ET